Company intelligence / Profile preview

Joyrise

Ownership: Private
Development stage: Other

Overview

Joyrise is a patented, science-backed hangover recovery aid designed to accelerate post-alcohol recovery by targeting acetaldehyde in the liver. The product claims rapid onset of action ("feel better in 30 minutes or less") and leverages vine tea as its primary active ingredient. Customer testimonials report effective relief from hangover symptoms and improved hydration/recovery compared to competitors.

Therapeutic areas: Metabolic DisordersOther
Modalities: Small moleculeNatural product extractDietary supplement
Industry: Food & Nutrition

Beyond the preview

Go deeper on Joyrise.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Joyrise.

Explore the full profile